UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapeutic applications of polymeric artificial cells

Nature reviews. Drug discovery, 2005-03, Vol.4 (3), p.221-235

Chang, Thomas Ming Swi

2005

Volltextzugriff (PDF)

Blood substitutes based on nanobiotechnology

Trends in biotechnology (Regular ed.), 2006-08, Vol.24 (8), p.372-377

Chang, Thomas Ming Swi

2006

Volltextzugriff (PDF)

Cell encapsulation: Promise and progress

Nature medicine, 2003-01, Vol.9 (1), p.104-107

2003

Volltextzugriff (PDF)

History, challenges and perspectives of cell microencapsulation

Trends in biotechnology (Regular ed.), 2004-02, Vol.22 (2), p.87-92

2004

Volltextzugriff (PDF)

Transdifferentiation of bioencapsulated bone marrow cells into hepatocyte‐like cells in the 90% hepatectomized rat model

Liver transplantation, 2006-04, Vol.12 (4), p.566-572

2006

Volltextzugriff (PDF)

Future generations of red blood cell substitutes

Journal of internal medicine, 2003-05, Vol.253 (5), p.527-535

Chang, T. M. S.

2003

Volltextzugriff (PDF)

Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties

Nature biotechnology, 1998-07, Vol.16 (7), p.667-671

1998

Volltextzugriff (PDF)

Hemoglobin-based Red Blood Cell Substitutes

Artificial organs, 2004-09, Vol.28 (9), p.789-794

Chang, Thomas Ming Swi

2004

Volltextzugriff (PDF)

Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

Nature medicine, 1996-08, Vol.2 (8), p.883-887

1996

Volltextzugriff (PDF)

Future prospects for artificial blood

Trends in Biotechnology, 1999-02, Vol.17 (2), p.61-67

Chang, Thomas M.S.

1999

Volltextzugriff (PDF)

Artificial Cells for Cell and Organ Replacements

Artificial organs, 2004-03, Vol.28 (3), p.265-270

Chang, Thomas Ming Swi

2004

Volltextzugriff (PDF)

A new red blood cell substitute

Critical care medicine, 2004-02, Vol.32 (2), p.612-613

Chang, Thomas Ming Swi

2004

Volltextzugriff (PDF)

A Different Approach to Treatment of Phenylketonuria: Phenylalanine Degradation with Recombinant Phenylalanine Ammonia Lyase

Proceedings of the National Academy of Sciences - PNAS, 1999-03, Vol.96 (5), p.2339-2344

1999

Volltextzugriff (PDF)

Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms

Molecular biotechnology, 2001-03, Vol.17 (3), p.249-260

2001

Volltextzugriff (PDF)

Bioencapsulated hepatocytes for experimental liver support

Journal of hepatology, 2001, Vol.34 (1), p.148-149

Chang, Thomas Ming Swi

2001

Volltextzugriff (PDF)

Pharmaceutical and therapeutic applications of artificial cells including microencapsulation

European journal of pharmaceutics and biopharmaceutics, 1998, Vol.45 (1), p.3-8

Chang, Thomas Ming Swi

1998

Volltextzugriff (PDF)

Live E. coli cells to treat uremia

Nature medicine, 1997-01, Vol.3 (1), p.2-4

Chang, T.M.S

1997

Volltextzugriff (PDF)

Red blood cell substitutes

Best practice & research. Clinical haematology, 2000-12, Vol.13 (4), p.651-667

Chang, Thomas Ming Swi

2000

Volltextzugriff (PDF)

Present Status of Modified Hemoglobin as Blood Substitutes and Oral Therapy for End Stage Renal Failure Using Artificial Cells Containing Genetically Engineered Cells

Annals of the New York Academy of Sciences, 2001-11, Vol.944 (1), p.362-372

CHANG, THOMAS MING SWI

2001

Volltextzugriff (PDF)

In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase

Biotechnology and bioengineering, 2004-06, Vol.86 (7), p.835-841

2004

Volltextzugriff (PDF)

Coencapsulation of hepatocytes and bone marrow stem cells: in vitro conversion of ammonia and in vivo lowering of bilirubin in hyperbilirubemia Gunn rats

International journal of artificial organs, 2003-06, Vol.26 (6), p.491-497

2003

Volltextzugriff (PDF)

Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in rats

Journal of pharmaceutical sciences, 2004-04, Vol.93 (4), p.831-837

2004

Volltextzugriff (PDF)

In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells

International journal of artificial organs, 2000-07, Vol.23 (7), p.429-435

2000

Volltextzugriff (PDF)

Comparison of polymerically stabilized PEG-grafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications

Biomaterials, 1998-07, Vol.19 (13), p.1167-1177

1998

Volltextzugriff (PDF)

Two future generations of blood substitutes based on polyhemoglobin–SOD–catalase and nanoencapsulation

Advanced drug delivery reviews, 2000-02, Vol.40 (3), p.213-218

2000

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)

Publikationsform

Artikel
(191)
Tagungsberichte
(1)

Sprache

Englisch
(192)

Erscheinungsjahr

n.n

Thema

Science & Technology
(167)
Engineering
(108)
Life Sciences & Biomedicine
(108)
Technology
(108)
Engineering, Biomedical
(101)
Animals
(88)
Materials Science
(85)
Materials Science, Biomaterials
(85)
Biological And Medical Sciences
(73)
Biotechnology & Applied Microbiology
(55)
Rats
(54)
Humans
(52)
Capsules
(39)
Male
(39)
Fundamental And Applied Biological Sciences. Psychology
(38)
Medical Sciences
(38)
Biotechnology
(33)
Membranes, Artificial
(25)
Artificial Cells
(24)
Biochemistry & Molecular Biology
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapeutic applications of polymeric artificial cells

Blood substitutes based on nanobiotechnology

Cell encapsulation: Promise and progress

History, challenges and perspectives of cell microencapsulation

Transdifferentiation of bioencapsulated bone marrow cells into hepatocyte‐like cells in the 90% hepatectomized rat model

Future generations of red blood cell substitutes

Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties

Hemoglobin-based Red Blood Cell Substitutes

Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

Future prospects for artificial blood

Artificial Cells for Cell and Organ Replacements

A new red blood cell substitute

A Different Approach to Treatment of Phenylketonuria: Phenylalanine Degradation with Recombinant Phenylalanine Ammonia Lyase

Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms

Bioencapsulated hepatocytes for experimental liver support

Pharmaceutical and therapeutic applications of artificial cells including microencapsulation

Live E. coli cells to treat uremia

Red blood cell substitutes

Present Status of Modified Hemoglobin as Blood Substitutes and Oral Therapy for End Stage Renal Failure Using Artificial Cells Containing Genetically Engineered Cells

In vitro and in vivo enzyme studies of polyhemoglobin-tyrosinase

Coencapsulation of hepatocytes and bone marrow stem cells: in vitro conversion of ammonia and in vivo lowering of bilirubin in hyperbilirubemia Gunn rats

Effects of long-term oral administration of polymeric microcapsules containing tyrosinase on maintaining decreased systemic tyrosine levels in rats

In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells

Comparison of polymerically stabilized PEG-grafted liposomes and physically adsorbed carboxymethylchitin and carboxymethyl/glycolchitin liposomes for biological applications

Two future generations of blood substitutes based on polyhemoglobin–SOD–catalase and nanoencapsulation

Aktive Filter

Suchergebnisse filtern